FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights FMR LLC (FMR) a provider of investment management solutions and offers account and trade, planning and advice, and investments.Account and trade contains portfolio management, trading, and cash management.
Planning and advice includes retirement solutions and wealth management planning and advisory.Investments offer annuities, mutual funds, stocks, bonds, certificate of deposits, credit cards, and exchange traded funds.
It also offers 529 college savings, life insurance, long-term care insurance, account management, and sector investing.The company offers its solutions to individual investors, advisors, institutions, and employers in North America, Europe, and Asia-Pacific.
FMR is headquartered in Boston, Massachusetts, the US.
FMR LLC Key Recent Developments Feb 07,2018: Fidelity appoints Vadim Zlotnikov as head of GAA division Feb 07,2018: Fidelity appoints Vadim Zlotnikov as head of GAA division Oct 02,2017: Michael R.Durbin named president of Fidelity Institutional Oct 02,2017: Michael R.
Durbin named president of Fidelity Institutional
Reasons to Buy - Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy. - Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. - Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Nasopharyngeal Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Pipeline Review, H2 2018, provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape. Nasopharyngeal cancer...
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2018 Summary According to the recently published report ’Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2018’; Transient...
Anal Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Pipeline Review, H2 2018, provides an overview of the Anal Cancer (Oncology) pipeline landscape. Anal cancer starts in the anus. Symptoms include...
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018 Summary According to the recently published report ’Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018’; Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 12 molecules. Out of which approximately...
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2018 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Complement component 5a receptor 1 (C5AR1) or CD88 is a G protein-coupled receptor for C5a. It functions as a complement receptor. Receptor activation...